FCA
PNT

FinTrust Capital Advisors’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

FinTrust Capital Advisors’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,000
Closed -$6.67K – 1357
2023
Q3 		$6.67K Hold
1,000
– – ﹤0.01% 854
2023
Q2 		$7.29K Hold
1,000
– – ﹤0.01% 817
2023
Q1 		$7.29K Hold
1,000
– – ﹤0.01% 812
2022
Q4 		$7.29K Buy
+1,000
New +$7.42K ﹤0.01% 810

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

FinTrust Capital Advisors's PNT Position: Q4 2023 in Review

FinTrust Capital Advisors sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 1,000 shares — an estimated $6.67K sold.

FinTrust Capital Advisors first reported a position in PNT in Q4 2022 and held it in 4 quarters. The position peaked at $7.29K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • FinTrust Capital Advisors reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • FinTrust Capital Advisors sold 1,000 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $6.67K.
  • FinTrust Capital Advisors first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • FinTrust Capital Advisors's POINT Biopharma Global Inc. Common Stock position peaked at $7.29K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on FinTrust Capital Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.